Search results
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
Zacks· 5 days agoThe recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Let's take a look at what these Wall Street ...
Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
Zacks via Yahoo Finance· 5 days agoShare Price Performance Over the past year, shares of BSX have skyrocketed 41.2% against the...
Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Zacks via Yahoo Finance· 5 days agoMedical - Products stocks are, on...rated industries outperform the bottom half by a factor of 2 to...
...Is Silk Road Medical (SILK) Stock Jumping Today? - Silk Road Medical (NASDAQ...), Boston...
Benzinga· 6 days agoBoston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio...
Why Is Silk Road Medical (SILK) Stock Up 24% Today?
InvestorPlace· 6 days agoThis deal has Boston Scientific agreeing to acquire shares of SILK stock for $27.50 each in cash. It’s also a 38% premium to the shares’ volume-weighted...
Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?
Zacks via Yahoo Finance· 7 days agoIt currently carries a Zacks Rank #2. Boston Scientific has a long-term estimated growth rate of...
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Lantheus and Haemonetics
Zacks via Yahoo Finance· 3 days agoCurrently, HAE sports a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks...
McKesson (MCK) Reaches 52-Week High: What's Aiding the Stock?
Zacks via Yahoo Finance· 3 days agoDVA, Boston Scientific Corporation BSX, and Ecolab Inc. ECL. DaVita, carrying a Zacks...four...
Top 7% Medtech Rockets On Boston Sci's $1.16 Billion Buyout
Investor's Business Daily· 5 days agoThe deal focuses on the company's stroke prevention product for patients with carotid artery...
Reasons to Retain The Cooper Companies (COO) in Your Portfolio Now
Zacks· 6 days agoFree Report) is well-poised for growth, backed by strong prospects in its CooperVision (CVI) and CooperSurgical (CSI) business segments. Acquisitions boost the company’s portfolio and buoy optimism ...